197 related articles for article (PubMed ID: 34282745)
21. Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.
Ben Abdallah H; Fogh K; Bech R
Int Wound J; 2019 Apr; 16(2):511-521. PubMed ID: 30604927
[TBL] [Abstract][Full Text] [Related]
22. [Pyoderma gangrenosum associated with anti-proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) induced by propylthiouracil].
Coster A; Dargent JL; de Visscher N; Levecque P; Roquet-Gravy PP
Ann Dermatol Venereol; 2017 May; 144(5):368-373. PubMed ID: 28291538
[TBL] [Abstract][Full Text] [Related]
23. Rare association of pyoderma gangrenosum and palmoplantar pustulosis: a case report and review of the previous works.
Ohtsuka M; Yamamoto T
J Dermatol; 2014 Aug; 41(8):732-5. PubMed ID: 24986043
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological features and prognosis of pyoderma gangrenosum in Korea: A single centre, retrospective, observational study over 20 years.
Kim YJ; Lee KH; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Indian J Dermatol Venereol Leprol; 2023; 89(1):25-34. PubMed ID: 35389018
[TBL] [Abstract][Full Text] [Related]
25. Understanding multi-kinase inhibitor-associated cutaneous ulcers may provide molecular insights into the aetiology of pyoderma gangrenosum: A comment on Jeon et al.
Pham JP; Flora A; Frew JW
Australas J Dermatol; 2024 May; 65(3):e81-e84. PubMed ID: 38337172
[No Abstract] [Full Text] [Related]
26. Pyoderma gangrenosum in a patient with essential thrombocythemia.
King KW; Murray A
J Cutan Med Surg; 2000 Apr; 4(2):107-9. PubMed ID: 11179935
[TBL] [Abstract][Full Text] [Related]
27. [Lung involvement in pyoderma gangrenosum: a case report and review of the literature].
Batalla A; Pérez-Pedrosa A; García-Doval I; González-Barcala FJ; Rosón E; de la Torre C
Actas Dermosifiliogr; 2011 Jun; 102(5):373-7. PubMed ID: 21397890
[TBL] [Abstract][Full Text] [Related]
28. Pyoderma gangrenosum: A clinico-epidemiological study.
Riyaz N; Mary V; Sasidharanpillai S; Roshin RA; Snigdha O; Latheef EN; Rahima S; Bindu V; Anupama RN; Sureshan DN; Sherjeena PV
Indian J Dermatol Venereol Leprol; 2017; 83(1):33-39. PubMed ID: 27549869
[TBL] [Abstract][Full Text] [Related]
29. Pyoderma gangrenosum and ulcerative colitis in the tropics.
Alese OB; Irabor DO
Rev Soc Bras Med Trop; 2008; 41(6):664-7. PubMed ID: 19142449
[TBL] [Abstract][Full Text] [Related]
30. [Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies)].
Boulenger-Vazel A; Kupfer-Bessaguet I; Gouedard C; Leberre R; Leroy JP; Sonnet E; Desvignes O; Misery L; Sassolas B
Ann Dermatol Venereol; 2005 Jan; 132(1):27-31. PubMed ID: 15746603
[TBL] [Abstract][Full Text] [Related]
31. Portable negative-pressure wound therapy for pyoderma gangrenosum: Report of two cases.
Yamaguchi Y; Yanagi T; Sato K; Yoshimoto N; Hirata Y; Ujiie I; Nishimura M; Natsuga K; Shiiya C; Tsukinaga I; Shimizu H
J Dermatol; 2018 Apr; 45(4):483-486. PubMed ID: 29235669
[TBL] [Abstract][Full Text] [Related]
32. Pyoderma Gangrenosum and Interleukin Inhibitors: A Semi-Systematic Review.
Ben Abdallah H; Fogh K; Vestergaard C; Bech R
Dermatology; 2022; 238(4):785-792. PubMed ID: 34710873
[TBL] [Abstract][Full Text] [Related]
33. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
34. Sunitinib-induced pyoderma gangrenosum-like skin ulcer.
Kuntz T; Koushk-Jalali B; Kreuter A
CMAJ; 2020 May; 192(20):E552. PubMed ID: 32452467
[No Abstract] [Full Text] [Related]
35. Takayasu arteritis with pyoderma gangrenosum: case reports and literature review.
Zhang X; Jiao Y
BMC Rheumatol; 2019; 3():45. PubMed ID: 31701086
[TBL] [Abstract][Full Text] [Related]
36. Pyoderma gangrenosum after orthopaedic or traumatologic surgery: a systematic revue of the literature.
Ebrad S; Severyns M; Benzakour A; Roze B; Derancourt C; Odri GA; Rouvillain JL
Int Orthop; 2018 Feb; 42(2):239-245. PubMed ID: 29119297
[TBL] [Abstract][Full Text] [Related]
37. Successful Treatment of Pyoderma Gangrenosum with Cryoglobulinemia and Hepatitis C.
Pourmorteza M; Tawadros F; Bader G; Al-Tarawneh M; Cook E; Shams W; Young M
Am J Case Rep; 2016 Jun; 17():434-8. PubMed ID: 27345376
[TBL] [Abstract][Full Text] [Related]
38. Pyoderma gangrenosum associated to the use of cocaine/levamisole. Series of three cases and literature review.
Martínez-Gómez M; Ramírez-Ospina JA; Ruiz-Restrepo JD; Velásquez-Lopera MM
An Bras Dermatol; 2021; 96(2):188-195. PubMed ID: 33640188
[TBL] [Abstract][Full Text] [Related]
39. Mucocutaneous pyoderma gangrenosum: a case report and literature review.
Đorđević Betetto L; Točkova O; Bergant Suhodolčan A
Acta Dermatovenerol Alp Pannonica Adriat; 2022 Mar; 31(Suppl):S10-S13. PubMed ID: 35339135
[TBL] [Abstract][Full Text] [Related]
40. [Extensive ulcerations in children: The difficulty diagnosing pyoderma gangrenosum].
Ramli I; Rachadi H; Amarouch H; Rimani M; Senouci K; Benzekri L; Hassam B
Arch Pediatr; 2015 Jul; 22(7):753-5. PubMed ID: 26047747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
